GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
February 27, 2024 07:45 ET
|
The Greater Cannabis Company, Inc.
BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation...
GCANRx Featured in American Journal of Endocannabinoid Medicine
September 21, 2023 08:29 ET
|
The Greater Cannabis Company, Inc.
BALTIMORE, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next...
Greater Cannabis CEO to be Interviewed Today on Yahoo Finance Live at 12:40pm EST
September 23, 2019 08:56 ET
|
The Greater Cannabis Company, Inc.
CEO will appear on the On The Move show to discuss Company’s technology as a high-tech alternative to vaping devices, why the GCANRx patch is safer, and what’s in the pipeline for the future. ...
Greater Cannabis Company Partners with Allume Cosmeticos To Develop New Cosmetics Line
April 11, 2019 09:08 ET
|
The Greater Cannabis Company, Inc.
Agreement with Leading Beauty And Personal Care Brand In Brazil Represents Company’s First Contract in Emerging CBD Cosmetics and Beauty Market BALTIMORE, MD, April 11, 2019 (GLOBE NEWSWIRE) --...
Greater Cannabis Company Announces Expansion Into CBD Cosmetics And Beauty Market
April 09, 2019 08:45 ET
|
The Greater Cannabis Company, Inc.
BALTIMORE, MD, April 09, 2019 (GLOBE NEWSWIRE) -- Greater Cannabis Company (OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems,...